Brief: Arcus Biosciences Q4 Operating Expenses USD 147 Million
25/02/2026 21:05
Feb 25 (Reuters) - Arcus Biosciences Q4 pretax profit USD -106 million. Q4 operating income USD -114 million Q4 net income USD -106 million
Recent news on Arcus Biosciences
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Arcus Biosciences tumbles on $250 mln share sale
Brief: Arcus Biosciences Announces Pricing Of $250 Million Public Offering Of Common Stock
Arcus Biosciences drops after starting stock offering